French diagnostics spending continues to fall:
This article was originally published in Clinica
French reimbursement for diagnostic tests fell 0.7% in April compared with a slight fall in March of 0.1% over the previous month. Spending on auxiliary procedures, which include EEGs and ECGs, fell 1.2% in April compared with a rise of 0.3% in March. Figures from national medical insurers CNAM show reimbursement for small equipment was Fr 89.5 million ($17.5 million) during the month and Fr 93.3 million for large equipment. April reimbursement for pacemakers was Fr 18.4 million and for other internal prostheses Fr 224.4 million. Total health reimbursement was down 0.4% for the month to Fr 35,505 million.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.